Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      USFDA completes inspection of Strides Pharma flagship unit in Bengaluru

      USFDA completes inspection of Strides Pharma flagship unit in Bengaluru

      Medical Dialogues Bureau22 July 2019 9:30 AM IST
      The flagship facility of Strides Pharma in Bangalore is the largest manufacturing facility for the company with capabilities to produce finished...
      Merck combo drug Recarbrio wins USFDA nod for treating cUTI, abdominal infection

      Merck combo drug Recarbrio wins USFDA nod for treating cUTI, abdominal infection

      Medical Dialogues Bureau22 July 2019 9:15 AM IST
      Recarbrio, approved for patients over 18 years of age, is a combination of a previously approved antibiotic imipenem-cilastatin and Merck & Co’s...
      Delhi HC restricts Lee Pharma from infringing copyright of Mankind Pharma

      Delhi HC restricts Lee Pharma from infringing copyright of Mankind Pharma

      Medical Dialogues Bureau21 July 2019 4:30 PM IST
      Justice Prathiba M Singh said considering the evidence and the content of the website of Lee Pharmaceuticals of Lee House being identical, a permanent...
      Zydus Cadila arm gets USFDA nod for generic version of Adderall XR capsules in US

      Zydus Cadila arm gets USFDA nod for generic version of Adderall XR capsules in US

      Medical Dialogues Bureau21 July 2019 10:00 AM IST
      The product is a generic version of Adderall XR capsules and will be manufactured at Nesher Pharmaceuticals' manufacturing facility at St Louis in the...
      USFDA grants final nod to Caplin Point arm for Tranexamic Acid Injection

      USFDA grants final nod to Caplin Point arm for Tranexamic Acid Injection

      Medical Dialogues Bureau21 July 2019 9:45 AM IST
      Tranexamic Acid Injection is a generic therapeutic equivalent version of Cyklokapron Injection, 100 mg/ml, of Pharmacia & Upjohn Company.Chennai:...
      Teva Pharma wins USFDA approval for AirDuo Digihaler Inhalation Powder

      Teva Pharma wins USFDA approval for AirDuo Digihaler Inhalation Powder

      Medical Dialogues Bureau21 July 2019 9:30 AM IST
      Teva Pharma's AirDuo Digihaler is indicated for the treatment of asthma in patients aged 12 years and older. AirDuo Digihaler is not used to relieve...
      USFDA to review Sanofi isatuximab for treatment of multiple myeloma

      USFDA to review Sanofi isatuximab for treatment of multiple myeloma

      Medical Dialogues Bureau21 July 2019 9:15 AM IST
      Sanofi Isatuximab targets a specific epitope on the CD38 receptor. It is designed to trigger multiple, distinct mechanisms of action that are believed...
      JnJ, Oklahoma to wrap up first trial over opioid crisis

      JnJ, Oklahoma to wrap up first trial over opioid crisis

      Medical Dialogues Bureau21 July 2019 9:00 AM IST
      Lawyers for Attorney General Mike Hunter and JnJ are set to deliver closing arguments in state court in Norman, Oklahoma following six weeks of...
      Strides Pharma found destroying, dumping drug production documents: USFDA Investigation

      Strides Pharma found destroying, dumping drug production documents: USFDA Investigation

      Medical Dialogues Bureau20 July 2019 2:16 PM IST
      In the letter to Strides Pharma, the FDA didn't explain whether its inspectors often check scrap yards or shredding rooms for documents, or whether it...
      Cipla gets 7 USFDA observations for Bengaluru API unit

      Cipla gets 7 USFDA observations for Bengaluru API unit

      Medical Dialogues Bureau20 July 2019 12:05 PM IST
      New Delhi: Drug firm Cipla recently said the US health regulator conducted an inspection at its API manufacturing facility in Virgonangar, Bengaluru...
      Dr Reddys unveils generic version of Allegra D in US to treat common cold, flu

      Dr Reddys unveils generic version of Allegra D in US to treat common cold, flu

      Medical Dialogues Bureau20 July 2019 11:37 AM IST
      In a BSE filing, Dr Reddy's Labs(Dr Reddys) announced "launch of Fexofenadine HCI 60 mg and Pseudoephedrine HCI 120 mg extended-release tablets, USP,...
      Novartis CEO sets aside 700 Million Dollar to settle doctor bribery lawsuit

      Novartis CEO sets aside 700 Million Dollar to settle doctor bribery lawsuit

      Medical Dialogues Bureau20 July 2019 9:52 AM IST
      ZURICH: Novartis Chief Executive Vas Narasimhan set aside $700 million to settle a U.S. doctor bribery lawsuit, as the Swiss drugmaker seeks to close...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok